Paolo Pucci

CIK 1436861 · Chief Executive Officer · last filed 2026-05-06

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

80

Lifetime Open-Market Net

-$206.3K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
WSTw Director 11,854 $0 12 2026-05-06
REPL Director $8.88 $0 7 2026-04-07
Merus N.V. (MRUS) Delisted Director $90.00 $0 7 2025-12-12
LUMOS PHARMA, INC. (NLNK) Delisted Director $0 3 2018-05-25
DYAX CORP (DYAX) Delisted Director 0 -$206.3K 6 2016-01-22

Recent Filings · Page 3 of 8

80 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2020-05-07 WSTw Grant (A) +975 $0 EDGAR
2020-04-02 REPL Grant (A) $0 EDGAR
2020-01-16 Mixed −1,235,782 -$24.72M
2019-12-20 Mixed +525,858 -$7.28M
2019-09-12 Exer (M) +5,000 $39.8K
2019-05-09 WSTw Grant (A) +1,565 $0 EDGAR
2019-03-18 Exer (M) +50,000 $58.0K
2019-03-14 Grant (A) $0
2019-01-17 Grant (A) $0
2018-07-25 Grant (A) $0
Showing 2130 of 80
Page 3 of 8
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.